According to the “Hematology Analyzers & Reagents Market – Forecasts to 2019” report published by Research and Markets, the global hematology market will see high growth in three emerging BRIC countries – China, India, and Brazil – in the next five years, and a lower CAGR in developed countries.
The report classifies the global hematology market on the basis of type of product (hematology instruments and consumables) and services, and by end-users (commercial organizations, stand alone hospitals, research institutes, and clinical testing labs).
The study identifies the factors driving the growth of the hematology analyzers and reagents market as
- increasing adoption of automated hematology instruments by diagnostics laboratories
- growing development of the high throughput hematology analyzers
- integration of basic flow-cytometry techniques in modern hematology analyzers
- developments in high sensitivity Point-of-Care hematology testing
- introduction of technologically advanced hematology instruments
In a healthcare setting, a hematology laboratory is involved in the diagnosis and monitoring of diseases of the blood and blood-forming organs. Modern hematology lab equipment is designed to provide accurate and consistent results which are crucial for healthcare providers to ensure timely care and improve patient outcomes and knowledge.
However, the growth of the hematology market in emerging nations is restricted by many factors, says the report. These include slow adoption of advanced hematology instruments in these economies, hematology product recalls, and the high cost of hematology analyzers.
In addition to the rapid growth of the hematology market in the BRIC nations, the introduction of digital imaging systems in hematology labs and growing adoption of microfluidics technology in hematology systems are expected to drive the growth of the hematology analyzers and reagents market in these countries. Sysmex Corporation, Abbott Laboratories, Beckman Coulter, Roche Diagnostics and Siemens Healthcare are among the leading players in the global hematology market.